4244 Crystal Growth & Design, Vol. 10, No. 10, 2010
Eccles et al.
have shown sulfoxides acting as a general co-former with a series
of NH compounds ranging from amines, (thio)amides, sulfona-
mides, thiourea etc. Critically, N-H OdS hydrogen bonding
3 3 3
is a key component of these structures, in direct contrast with
Bernstein’s observation that water was required to bridge the two
components.
Interestingly, for six of the seven co-crystals key structure
determining hydrogen bond motifs are retained from the co-
former, while this is not possible for the seventh, 3f. The R22 (8)
dimer is retained in four cases, and C(4) chains are retained in a
further two. The sulfoxide is bifurcated in three cases when the
dimer is retained and acts in a discrete fashion in all other cases.
Further work is underway to gain a fuller understanding of the
influence of the sulfoxide on the final hydrogen bonded motifs
found in the co-crystals.
Figure 1. The co-formers investigated in this work.
In conclusion, the potent hydrogen bonding acceptor ability of
sulfoxides render them excellent co-formers with a wide variety of
N-H donors. Notably, co-crystallization with sulfoxides is not
complicated by proton transfer and salt formation since they are
poorlybasic, asexemplifiedbyformation ofco-crystal 3f contain-
ing the relatively acidic saccharin, which displays a high propen-
sity for salt formation in the solid state. Preliminary results have
been obtained using sulfoxides as co-formers with phenols and
sulfonic acids, among other groups, which will be published in
due course.
Figure 2. The R22 (8) dimer in 3a, capped by the sulfoxide.
As the sulfoxide functionality is common in a significant
number of APIs, this fundamental exploration into its ability as
a co-former may well lead to improvements in drug development.
Acknowledgment. This publication has emanated from re-
search conducted with the financial support of Science Founda-
tion Ireland under Grant Nos. 08/RFP/MTR1664 (KE), 07/
SRC/B1158 (CE), and 05/PICA/B802/EC07.
Supporting Information Available: Crystallographic data of 1b,
2a, 3a-3f, Figures showing the hydrogen-bonding in 3b-3d, 3f, and
3g, and experimental details for 3a-3f. This material is available
Figure 3. The N-H CdO hydrogen bond leading to the C(4)
chains in 3e, with the individual units of the chain capped by the
sulfoxide.
3 3 3
References
N-H OdC C(4) chain;19 see Figure 3. The amide hydrogen
3 3 3
(1) (a) Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J.
J. Pharm. Sci. 2006, 95, 499–516. (b) Shan, N.; Zaworotko, M. J. Drug
which is not involved in this chain is capped by the sulfoxide.
Notably, the weak hydrogen bonds between the benzylic protons
and the oxygen of dibenzyl sulfoxide, which are present in 1b,9,20
are also retained in this co-crystal. Such interactions have been
shown to be structure directing in organosulfur compounds.20,21
As expected, the R22 (8) dimer in 2f is not retained in 3f as
hydrogen bonding between the single N-H and the strong
€
Discovery Today 2008, 13, 440–446. (c) Aakeroy, C. B.; Desper, J.;
Leonard, B.; Urbina, J. F. Cryst. Growth Des. 2005, 5, 865–873.
(d) Ahn, S.; Kariuki, B. M.; Harris, K. D. M. Cryst. Growth Des. 2001,
1, 107–111. (e) Rafilovich, M.; Bernstein, J.; Hickey, M. B.; Tauber, M.
Cryst. Growth Des. 2007, 7, 1777–1782. (f) Blagden, N.; Berry, D. J.;
Parkin, A.; Javed, H.; Ibrahim, A.; Gavan, P. T.; De Matos, L. L.;
Seaton, C. C. New J. Chem. 2008, 32, 1659–1672. (g) Trask, A. V. Mol.
Pharmaceutics 2007, 4, 301–309. (h) Stahly, G. P. Cryst. Growth Des.
2009, 9, 4212–4229. (i) Kumar, V. S. S.; Nangia, A.; Katz, A. K.;
Carrell, H. L. Cryst. Growth Des. 2002, 2, 313–318.
sulfoxide acceptor overcomes the N-H OdC seen in 2f, and
3 3 3
the sulfoxide caps the N-H in a discrete fashion.9 As the CdO
bond is no longer involved in hydrogen bonding, an increase in
the CdO bond order and ν(CO) frequency is seen as mentioned
above.
(2) McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.;
Cassidy, J.; Shet, M . S.; Mannion, R.; O’Donnell, E.; Park, A.
Pharm. Res. 2006, 23, 1888–1897.
While co-former 2g is the only compound studied which does
not exhibit a dimer motif, interestingly the structure of 3g is
ꢀ
ꢀ
(3) Fabian, L. Cryst. Growth Des. 2009, 9, 1436–1443.
(4) Hunter, C. A. Angew. Chem., Int. Ed. 2004, 43, 5310–5324.
(5) (a) Kobayashi, Y.; Soetrisno; Kodama, K.; Saigo, K. Tetrahedron:
Asymmetry 2008, 19, 295–301. (b) Fantin, G.; Fogagnolo, M.;
Bortolini, O.; Masciocchi, N.; Galli, S.; Sironi, A. New J. Chem.
2004, 28, 1295–1300. (c) Toda, F.; Tanaka, K.; Mak, T. C. W. Chem.
Lett. 1984, 2085–2088. (d) Toda, F.; Tanaka, K.; Miyamoto, H.;
Koshima, H.; Miyahara, I.; Hirotsu, K. J. J. Chem. Soc. Perkin Trans.
2 1997, 1877–1885. (e) Ishizuka, K.; Kawanami, T.; Furuno, H.;
Inanaga, J. Acta Crystallogr. 2004, E60, o607–o609.
similar to the other co-crystals. There is a N-H OdS C(4)
3 3 3
chain linking the sulfonamide molecules, which is retained from
the structure of 2e, with the sulfoxide capping the remaining
hydrogen, in a fashion similar to 3e.9
For all structures, there are no significant differences in the
SdO bonddistance between the sulfoxideco-former9,20,22 and the
sulfoxide in the co-crystals, despite the observed changes in the
ν(SO) frequencies.
As mentioned in the introduction, the sulfoxide group has been
shown to interact via hydrogen bonding with alcohols and
carboxylic acids,1h,1i,5 as well as with the positively charged ammo-
nium group.6 In view of the report by Bernstein that 1a does not
tend to form co-crystals,1e it is particularly significant that we
(6) (a) Akazome, M.; Doba, A.; Matsumoto, S.; Ogura, K. J. Org.
Chem. 2010, 75, 660–665. (b) Akazome, M.; Ueno, Y.; Ooiso, H.;
Ogura, K. J. Org. Chem. 2000, 65, 68–76.
~
(7) Kagan, H. B.; Charpin, P.; Dunach, E.; Theobald, F. R. Tetra-
hedron Lett. 1986, 27, 2989–2992. Only unit-cell dimensions are in the
CSD.